IM Cannabis (IMCC) Return on Capital Employed (2022 - 2026)
IM Cannabis (IMCC) posted quarterly Return on Capital Employed of 5007.95% for Q1 2026, up 526680.0% year-over-year from N/an in Q1 2025, and up 1958.54% quarter-over-quarter from 269.46% in Q4 2025.
IM Cannabis (IMCC) Return on Capital Employed (2022 - 2026) Analysis & Trends
IM Cannabis' Return on Capital Employed history runs 5 years deep, the most recent figure standing at 5007.95% for Q1 2026.
- In Q1 2026, Return on Capital Employed rose 526680.0% year-over-year to 5007.95%; the TTM figure through Mar 2026 stood at 5007.95% (up 526680.0% YoY), while the FY2025 annual figure was 636.73%, down 52834.0% from the prior year.
- Return on Capital Employed for Q1 2026 stood at 5007.95%, up from 269.46% in the prior quarter.
- The five-year high for Return on Capital Employed was 5007.95% in Q1 2026, with the low at 959.17% in Q3 2024.
- The 5-year median for Return on Capital Employed is 124.81% (2025), against an average of 128.8%.
- The sharpest annual moves came in 2024 and 2026: Return on Capital Employed sank 79514 bps in 2024, then surged 526680 bps in 2026.
- IM Cannabis' Return on Capital Employed stood at 46.54% in 2022, then slumped by 50 bps to 70.01% in 2023, then slumped by 100 bps to 139.77% in 2024, then plunged by 93 bps to 269.46% in 2025, then jumped by 1959 bps to 5007.95% in 2026.
- Business Quant data shows IMCC's Return on Capital Employed at 5007.95% in Q1 2026, 269.46% in Q4 2025, and 124.81% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 6.60% |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 17.16% |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 6.07% |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 22.04% |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -0.29% |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 18.67% |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 5.52% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | IM Cannabis | 554,496.00 | -614,474.17 | 1.09 Mn | 298.79% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 298.79% |
| Mar 31, 2026 | 5,007.95% |
| Dec 31, 2025 | -269.46% |
| Sep 30, 2025 | -124.81% |
| Jun 30, 2025 | -27.40% |
| Mar 31, 2025 | -258.85% |
| Dec 31, 2024 | -139.77% |
| Sep 30, 2024 | -959.17% |
| Jun 30, 2024 | -354.03% |
| Mar 31, 2024 | -153.32% |
| Dec 31, 2023 | -70.01% |
| Sep 30, 2023 | -164.03% |
| Jun 30, 2023 | -140.46% |
| Mar 31, 2023 | -108.52% |
| Dec 31, 2022 | -46.54% |
| Sep 30, 2022 | 7.44% |
| Jun 30, 2022 | -1.13% |
| Mar 31, 2022 | -8.29% |